Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Feb;41(2):159–167. doi: 10.1038/bjc.1980.26

Single-cell immunofluorescence assay for terminal transferase: Human leukaemic and non-leukaemic cells

S Okamura, F Crane, N Jamal, H A Messner, T W Mak
PMCID: PMC2010186  PMID: 6989382

Abstract

The characteristics of a single-cell immunofluorescence assay for terminal deoxynucleotidyl transferase (terminal transferase, TdT) is described. The data indicate that the single-cell immunofluorescence assay is highly efficient and specific for the detection of cells containing TdT. Using this assay, we have examined 124 marrow or peripheral-blood samples from 104 patients with or without haematological malignancies. Results indicate that TdT+ cells from 6% to 100% were found in the following patients: 34/40 samples from patients with ALL at the time of diagnosis or during relapse; 2/3 patients with acute undifferentiated leukaemia; 2/3 patients with acute myelomonocytic leukaemia; 1/24 patients with acute myeloblastic leukaemia; 1/5 patients with chronic myelocytic leukaemia (CML) in blastic crisis; and 2/2 patients with diffuse lymphoblastic lymphoma. In contrast less than 1% of TdT+ cells were found in 20 marrow or peripheral-blood samples from ALL patients in complete remission; 8 patients with CML in chronic phase; 2 patients with myeloma; 1 sample from a patient with Hodgkin's disease, peripheral-blood samples from 7 normal donors and marrow samples from 6 patients without haematological malignancies. TdT+ cells were also found in association with cells with lymphoblast morphology. The TdT+ cells in marrow were shown to be directly correlated with the percentage of morphological lymphoblasts, with a Spearman rank coefficient of 0·81, significant at a 0·001 level. In 2 longitudinal studies of 2 ALL patients with TdT+ cells at diagnosis, the percentage TdT+ cells also changed in parallel with the proportion of lymphoblasts. However, studies of 2 other patients with morphologically diagnosed ALL with < 1% TdT+ cells at diagnosis also showed < 1% TdT+ cells throughout the period studied, indicating a stable phenotype of blast cells in these patients. The single-cell immunofluorescence assay for TdT, which requires < 0·1% of the cells used in a conventional biochemical assay, is highly specific, and could provide a technically more efficient alternative for use in clinics as well as in experimental investigations of subpopulations of leukaemic and normal marrow cells.

Full text

PDF
159

Images in this article

161Fig. 1
on p.161

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernstein A., Mak T. W., Stephenson J. R. The Friend virus genome: evidence for the stable association of MuLV sequences and sequences involved in erythroleukemic transformation. Cell. 1977 Sep;12(1):287–294. doi: 10.1016/0092-8674(77)90206-9. [DOI] [PubMed] [Google Scholar]
  2. Bhattacharyya J. R. Terminal deoxyribonucleotidyl transferase in human leukemia. Biochem Biophys Res Commun. 1975 Jan 20;62(2):367–375. doi: 10.1016/s0006-291x(75)80148-3. [DOI] [PubMed] [Google Scholar]
  3. Bollum F. J. Terminal deoxynucleotidyl transferase: biological studies. Adv Enzymol Relat Areas Mol Biol. 1978;47:347–374. doi: 10.1002/9780470122921.ch6. [DOI] [PubMed] [Google Scholar]
  4. Coleman M. S., Greenwood M. F., Hutton J. J., Bollum F. J., Lampkin B., Holland P. Serial observations on terminal deoxynucleotidyl transferase activity and lymphoblast surface markers in acute lymphoblastic leukemia. Cancer Res. 1976 Jan;36(1):120–127. [PubMed] [Google Scholar]
  5. Coleman M. S., Hutton J. J., De Simone P., Bollum F. J. Terminal deoxyribonucleotidyl transferase in human leukemia. Proc Natl Acad Sci U S A. 1974 Nov;71(11):4404–4408. doi: 10.1073/pnas.71.11.4404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Greenwood M. F., Coleman M. S., Hutton J. J., Lampkin B., Krill C., Bolium F. J., Holland P. Terminal deoxynucleotidyltransferase distribution in neoplastic and hematopoietic cells. J Clin Invest. 1977 May;59(5):889–899. doi: 10.1172/JCI108711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gregoire K. E., Goldschneider I., Barton R. W., Bollum F. J. Intracellular distribution of terminal deoxynucleotidyl transferase in rat bone marrow and thymus. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3993–3996. doi: 10.1073/pnas.74.9.3993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hasselback R., Curtis J., Soots M., Robertson G. L., Cowan D. H., Hart G. D. The influence of morphology on prognosis in acute leukemia. Can Med Assoc J. 1967 Jun 24;96(25):1610–1614. [PMC free article] [PubMed] [Google Scholar]
  9. Hoffbrand A. V., Ganeshaguru K., Janossy G., Greaves M. F., Catovsky D., Woodruff R. K. Terminal deoxynucleotidyl-transferase levels and membrane phenotypes in diagnosis of acute leukaemia. Lancet. 1977 Sep 10;2(8037):520–523. doi: 10.1016/s0140-6736(77)90662-6. [DOI] [PubMed] [Google Scholar]
  10. Hutton J. J., Coleman M. S. Terminal deoxynucleotidyl transferase measurements in the differential diagnosis of adult leukaemias. Br J Haematol. 1976 Nov;34(3):447–456. doi: 10.1111/j.1365-2141.1976.tb03591.x. [DOI] [PubMed] [Google Scholar]
  11. Kung P. C., Long J. C., McCaffrey R. P., Ratliff R. L., Harrison T. A., Baltimore D. Terminal deoxynucleotidyl transferase in the diagnosis of leukemia and malignant lymphoma. Am J Med. 1978 May;64(5):788–794. doi: 10.1016/0002-9343(78)90518-1. [DOI] [PubMed] [Google Scholar]
  12. Marks S. M., Baltimore D., McCaffrey R. Terminal transferase as a predictor of initial responsiveness to vincristine and prednisone in blastic chronic myelogenous leukemia: a co-operative study. N Engl J Med. 1978 Apr 13;298(15):812–814. doi: 10.1056/NEJM197804132981503. [DOI] [PubMed] [Google Scholar]
  13. McCaffrey R., Harrison T. A., Parkman R., Baltimore D. Terminal deoxynucleotidyl transferase activity in human leukemic cells and in normal human thymocytes. N Engl J Med. 1975 Apr 10;292(15):775–780. doi: 10.1056/NEJM197504102921504. [DOI] [PubMed] [Google Scholar]
  14. McCaffrey R., Smoler D. F., Baltimore D. Terminal deoxynucleotidyl transferase in a case of childhood acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 1973 Feb;70(2):521–525. doi: 10.1073/pnas.70.2.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Okamura S., Crane F., Messner H. A., Mak T. W. Purification of terminal deoxynucleotidyltransferase by oligonucleotide affinity chromatography. J Biol Chem. 1978 Jun 10;253(11):3765–3767. [PubMed] [Google Scholar]
  16. Sahai Srivastava B. I., Khan S. A., Henderson E. S. High terminal deoxynucleotidyl transferase activity in acute myelogenous leukemia. Cancer Res. 1976 Oct;36(10):3847–3850. [PubMed] [Google Scholar]
  17. Sarin P. S., Anderson P. N., Gallo R. C. Terminal deoxynucleotidyl transferase activities in human blood leukocytes and lymphoblast cell lines: high levels in lymphoblast cell lines and in blast cells of some patients with chronic myelogenous leukemia in acute phase. Blood. 1976 Jan;47(1):11–20. [PubMed] [Google Scholar]
  18. Taylor J. M., Schimke R. T. Specific binding of albumin antibody to rat liver polysomes. J Biol Chem. 1974 Jun 10;249(11):3597–3601. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES